REGENXBIO Inc. (RGNX)
$8.09+6.45%Close
SELLRECOVERY · day 4
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $418M
- Beta
- 0.93
- P/E (TTM)
- -1.97
- Short % float
- 17.84%
- Days to cover
- 7.7
- SI change
- +5.7%
- 1W
- +9.03%
- 1M
- -7.33%
- vs SPY 1W
- +7.47%
- vs SPY 1M
- -9.10%
Industry peers
FMP comparable companies · ranked by market cap
- ABSIBUYAbsci Corporation$1.9BCRISISQ 2$11.07-3.04%
- KALVKalVista Pharmaceuticals, Inc.$1.4B$27.00
- VTYXVentyx Biosciences, Inc.$1.0B$14.00
- MLTXSELLMoonLake Immunotherapeutics$960MCRISISQ -0$11.41-1.76%
- CRVSSELLCorvus Pharmaceuticals, Inc.$917MCRISISQ 13$10.90-1.92%
- OLMASELLOlema Pharmaceuticals, Inc.$718MCRISISQ -1$8.22-1.51%
- FDMTSELL4D Molecular Therapeutics, Inc.$715MCRISISQ 4$13.67+0.87%
- VSTMBUYVerastem, Inc.$677MRECOVERYQ 4$7.70-1.93%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
